La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Cyclopharm Crescita futura
Future criteri di controllo 0/6
Informazioni chiave
94.9%
Tasso di crescita degli utili
94.6%
Tasso di crescita dell'EPS
Medical Equipment crescita degli utili | 16.0% |
Tasso di crescita dei ricavi | 32.6% |
Rendimento futuro del capitale proprio | 27.3% |
Copertura analitica | Low |
Ultimo aggiornamento | 03 Jul 2024 |
Aggiornamenti recenti sulla crescita futura
Recent updates
What You Can Learn From Cyclopharm Limited's (ASX:CYC) P/SAfter Its 26% Share Price Crash
Oct 28Is Cyclopharm Limited (ASX:CYC) Trading At A 25% Discount?
Apr 18Companies Like Cyclopharm (ASX:CYC) Are In A Position To Invest In Growth
Mar 31Companies Like Cyclopharm (ASX:CYC) Can Afford To Invest In Growth
Oct 17Companies Like Cyclopharm (ASX:CYC) Can Afford To Invest In Growth
Jun 09Analyst Forecasts For Cyclopharm Limited (ASX:CYC) Are Surging Higher
Mar 06Here's Why We're Not At All Concerned With Cyclopharm's (ASX:CYC) Cash Burn Situation
Mar 02We Think Cyclopharm (ASX:CYC) Can Afford To Drive Business Growth
Oct 22Cyclopharm Limited's (ASX:CYC) Analyst Just Slashed This Year's Estimates
Jun 29Shareholders Will Probably Hold Off On Increasing Cyclopharm Limited's (ASX:CYC) CEO Compensation For The Time Being
Apr 27Rainbows and Unicorns: The Cyclopharm Limited (ASX:CYC) Analyst Just Became A Lot More Optimistic
Mar 01Cyclopharm (ASX:CYC) Has Rewarded Shareholders With An Exceptional 401% Total Return On Their Investment
Feb 07Is Cyclopharm Limited (ASX:CYC) Popular Amongst Insiders?
Jan 02We're Not Very Worried About Cyclopharm's (ASX:CYC) Cash Burn Rate
Dec 06Previsioni di crescita degli utili e dei ricavi
Data | Ricavi | Guadagni | Flusso di cassa libero | Liquidità dell'operazione | Avg. Numero di analisti |
---|---|---|---|---|---|
12/31/2026 | 70 | 13 | 11 | 14 | 1 |
12/31/2025 | 50 | 0 | -1 | 3 | 1 |
12/31/2024 | 32 | -8 | -10 | -8 | 1 |
12/31/2023 | 27 | -5 | -8 | -7 | N/A |
9/30/2023 | 28 | -6 | -8 | -7 | N/A |
6/30/2023 | 29 | -7 | -8 | -7 | N/A |
3/31/2023 | 27 | -7 | -8 | -7 | N/A |
12/31/2022 | 25 | -7 | -8 | -7 | N/A |
9/30/2022 | 24 | -5 | -6 | -4 | N/A |
6/30/2022 | 23 | -4 | -4 | -2 | N/A |
3/31/2022 | 21 | -4 | -3 | -2 | N/A |
12/31/2021 | 20 | -5 | -3 | -2 | N/A |
9/30/2021 | 20 | -5 | -5 | -4 | N/A |
6/30/2021 | 20 | -4 | -7 | -6 | N/A |
3/31/2021 | 19 | -5 | -8 | -8 | N/A |
12/31/2020 | 18 | -6 | -9 | -9 | N/A |
9/30/2020 | 17 | -6 | -7 | -7 | N/A |
6/30/2020 | 16 | -6 | -6 | -5 | N/A |
3/31/2020 | 17 | -4 | -3 | -3 | N/A |
12/31/2019 | 17 | -3 | -1 | 0 | N/A |
9/30/2019 | 16 | -3 | -1 | 0 | N/A |
6/30/2019 | 16 | -2 | -1 | 0 | N/A |
3/31/2019 | 16 | -1 | -1 | -1 | N/A |
12/31/2018 | 16 | 0 | -2 | -1 | N/A |
9/30/2018 | 16 | 0 | -2 | -1 | N/A |
6/30/2018 | 16 | -1 | -1 | 0 | N/A |
3/31/2018 | 16 | -1 | -2 | 0 | N/A |
12/31/2017 | 16 | -2 | -2 | -1 | N/A |
9/30/2017 | 15 | -1 | N/A | 0 | N/A |
6/30/2017 | 14 | -1 | N/A | 0 | N/A |
3/31/2017 | 15 | 0 | N/A | 0 | N/A |
12/31/2016 | 15 | 1 | N/A | 1 | N/A |
9/30/2016 | 14 | 3 | N/A | 2 | N/A |
6/30/2016 | 14 | 5 | N/A | 4 | N/A |
3/31/2016 | 13 | 5 | N/A | 4 | N/A |
12/31/2015 | 13 | 5 | N/A | 4 | N/A |
9/30/2015 | 12 | 4 | N/A | 4 | N/A |
6/30/2015 | 11 | 3 | N/A | 4 | N/A |
3/31/2015 | 11 | 4 | N/A | 4 | N/A |
12/31/2014 | 12 | 4 | N/A | 4 | N/A |
9/30/2014 | 13 | -2 | N/A | 3 | N/A |
6/30/2014 | 14 | -8 | N/A | 2 | N/A |
3/31/2014 | 13 | -9 | N/A | 1 | N/A |
12/31/2013 | 12 | -10 | N/A | 1 | N/A |
9/30/2013 | 12 | -6 | N/A | 0 | N/A |